Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 992-998, May 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chernozemski, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernozemski, I. N.

Cell Proliferation Studies in Syrian Hamsters following Vinblastine Treatment

Ivan N. Chernozemski

Oncological Research Institute, 56, Sofia, Bulgaria

The dose-effect and the time-effect of i.p. injected Velbe (vinblastine sulfate, Lilly) on mitotic cells were studied in normal and tumorous hamster tissues. A dose of 1 mg/kg of body weight appeared suitable to jejunal crypt cells while most blocked metaphases in skin and cheek-pouch epithelium were counted at doses of 1.5 mg/kg and 5 mg/kg respectively. Metaphase increment in the jejunal crypts showed an approximately linear pattern up to the 4th hour, followed by a decrement at the 6th and 8th hours after the injection. Decrement was also noticed in stratified epithelium examined at the 9th hour. A striking stability of the prophase counts characterized the results obtained from all tissues examined. Velbe blocked mitoses in early or middle metaphases. The latter were normally detected as ball forms. Manifest cell degeneration was observed only in crypt cells following doses over 1 mg/kg and treatment longer than 3–4 hours.

Received 9/18/67. Accepted 1/15/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.